ArticleInvestigational new drugs2023

The ATR inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines.

Julia Schnoell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.